On this Veteran’s Day, we honor and express our sincere gratitude to all Indivior employees and men and women who have served our country. Their dedication and sacrifices have safeguarded our freedom and security, and we are profoundly grateful. As we celebrate our veterans today, let’s also commit to supporting them in their battles off the battlefield. In recent years, the veteran community has seen an increase in opioid overdose deaths.* By raising awareness and advocating for better access to evidence-based treatment, Indivior helps saving lives and provide the care our veterans deserve. *Begley M.R, et al. Veteran drug overdose mortality, 2010-2019. Drug and Alcohol Dependence. 2022, 233 Veteran drug overdose mortality, 2010–2019 - ScienceDirect
关于我们
Indivior is a global pharmaceutical company working to help change patients’ lives by developing medicines to treat substance use disorder and serious mental illnesses. Our vision is that all patients around the world will have access to evidence-based treatment for the chronic conditions and co-occurring disorders of addiction. Indivior is dedicated to transforming addiction from a global human crisis to a recognized and treated chronic disease. Building on its global portfolio of opioid dependence treatments, Indivior has a pipeline of product candidates designed to both expand on its heritage in this category and potentially address other chronic conditions and co-occurring disorders of addiction, including alcohol use disorder. Headquartered in the United States in Richmond, VA, Indivior employs more than 1000 individuals globally and its portfolio of products is available in over 30 countries worldwide. Our guiding principles foster a corporate culture of trust, innovation, and a pioneering spirit: ? Focus on patient needs to drive decisions ? Seek the wisdom of the team ? Believe that people’s actions are well intended ? Care enough to coach ? See it, own it, make it happen ? Demonstrate honesty and integrity at all times Community guidelines: https://bit.ly/43QuKrw
- 网站
-
https://www.indivior.com
Indivior的外部链接
- 所属行业
- 制药业
- 规模
- 501-1,000 人
- 总部
- Richmond,VA
- 类型
- 上市公司
- 领域
- Opioid use disorder、Alcohol use disorder、Rescue Medications和Schizophrenia
地点
Indivior员工
-
Nicolas Fouché
Senior Vice-President, Head of Europe, Canada and Middle - East
-
Mark Stejbach
Biotech board member and consultant
-
Pauline Whelan
Government Affairs Executive for Specialty Pharma ? Strategic Planning + Strategy Execution that Secures State Funding | Lobbying Yielding…
-
Johan V.
Indivior
动态
-
The November 17, 2024 deadline to apply for the Indivior and University of Pittsburgh HEOR & Medical Affairs PharmD Fellowship Program is fast approaching. Eligible candidates are encouraged to check out the program brochure for additional details and attend our upcoming informational webinar on Tuesday November 5 from 12-1pm ET. Webinar and application links can be found at https://lnkd.in/eKd29Tff Please reach out to our current fellow Caroline Paley, PharmD or our program director Kangho Suh if you have any questions. #Fellowship #HEOR #MedicalAffairs #MedAffairs #Indivior #Pitt
-
News for #investors and #media: Indivior announces Q3 2024?financial results. Please read the press release here:?www.indivior.com/en/media
-
According to a research report by the National Institutes on Drug Abuse, “multiple national population surveys have found that about half of those who experience a mental illness during their lives will also experience a substance use disorder (SUD) and vice versa*.” These comorbidities play a role in making every patient’s recovery journey unique. Our Guiding Principle to “focus on patient needs to drive decisions,” means we support the patient's journey from treatment and recovery by providing education, new scientific understanding, and knowledge to the treatment community. *https://lnkd.in/eCdVrure
-
Attending #NCCHC Annual in Las Vegas? Visit the Indivior Medical Affairs team at Booth 104 and Commercial team at Booth 200 to learn more about innovative treatments for substance use disorders and overdose reversal. Don’t miss our opioid use disorder real-world evidence podium presentation (session 491) on Wednesday, October 23 from 11:15 AM - 12:15 PM PDT!?Also check out our lightning talk (session 445c) on Tuesday, October 22 from 2:30 PM - 3:00 PM PDT.
-
During Substance Use Prevention Month we recognize that substance use disorder (SUD) can affect any of us. Your sibling, child, parent, friend, coworker or others could be struggling with SUD and searching for help. At Indivior we want to thank the people and community leaders working every day to promote prevention and early intervention strategies so that more people suffering from SUD have access to care. Together, we can create a brighter future for people experiencing SUD. To learn more about prevention resources and events, visit SAMHSA’s website:?https://lnkd.in/edq9kCnA
-
At Indivior we weave our unwavering commitment to support patients along their journey through treatment and recovery into everything we do. We believe recovery is possible and together, we can help more patients get on the path to long-term recovery. Visit SAMHSA’s website to learn more about recovery support resources in your community: https://lnkd.in/gYCs3KAj
-
The Indivior and University of Pittsburgh Health Economics and Outcomes Research (HEOR) & Medical Affairs?PharmD Fellowship Program is now accepting applications by the November 17, 2024 deadline. Eligible candidates are encouraged to check out the program brochure for additional details, attend one of our?upcoming informational webinars (Thursday, October 10 from 3-4pm ET or Tuesday, November 5 from 12-1pm ET), and/or meet with our team at the AMCP Nexus Residency & Fellowship Showcase on October 16, 2024. Webinar and application links can be found at https://lnkd.in/eKd29Tff Please reach out to our current fellow Caroline Paley, PharmD or our program director Kangho Suh if you have any?questions. #Fellowship #HEOR #MedicalAffairs
-
Attending #ACEP24 in Las Vegas? Visit the Indivior Medical Affairs team at Booth 920 to learn more about innovative treatments for substance use disorders #SUD and overdose reversal. Don’t miss our opioid use disorder #OUD real-world evidence #RWE podium presentation RF47 on 10/1 at 10:00 AM PT in Room 3 within the Research Forum Exhibit Hall!